Most Read Articles
Rachel Soon, 3 days ago

Gels utilizing Stichopus horrens (golden sea cucumber/gamat) extract show a similar efficacy to standard-of-care hydrogels for promoting wound healing, according to a prospective study.

16 Mar 2019
Sleep difficulties are exacerbated in long-term survivors of childhood cancers, which may lead to persistent emotional distress, a new study has found.
2 days ago
Higher cancer symptom burden in elderly adults is associated with functional impairment, reports a recent study.
Jairia Dela Cruz, 5 days ago
Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.

Multiple sclerosis tied to sexual dysfunction in women

31 Dec 2018

Women with multiple sclerosis (MS) are at an elevated risk of sexual dysfunction, reports a recent meta-analysis.

After applying the selection criteria, nine studies were eligible for inclusion. The resulting overall sample size was 1,458 women (mean age range 29.15–45.89 years), of whom 826 were MS patients, with mean disease durations ranging from 2.7–16.51 years.

Five studies provided the number of patients with MS and the number of controls. A pooled analysis revealed that the risk of female sexual dysfunction was almost twice that in MS patients than in controls (relative risk, 1.87; 95 percent CI, 1.25–2.78; p=0.002).

In comparison, the four remaining studies reported scores in the Female Sexual Function Index (FSFI). A meta-analysis showed significantly lower scores in women with MS (standardized mean difference [SMD], –2.41; –3.87 to –0.96; p=0.017).

Because heterogeneity was significant in both analyses (p<0.001 and p=0.001, respectively), researchers performed a subgroup analysis based on age. They found that the risk of sexual dysfunction was higher in women with MS at least 40 years of age (RR, 1.94; 1.23–3.05; p=0.004) but not younger (RR, 1.64; 0.91–2.95; p=0.1).

Similar trends were obtained regarding FSFI, with scores being lower in MS patients aged ≥40 years (SMD, –2.95; –3.58 to –2.32) than in those <40 years (SMD, –2.23; –3.86 to –0.59).

Another subgroup analysis according to disease duration showed a higher risk of sexual dysfunction in those with MS duration <10 years (RR, 2.45; 1.1–5.37; p=0.028; >10 years: RR, 2.51; 0.56–11.19; p=0.228), but FSFI scores were worse in women with longer disease duration (>10 years: SMD, –5.43; –6.48 to –4.37; p<0.001; <10 years: SMD, –1.49; –2.61 to –0.36; p=0.009).

The findings of the present study indicate that there is a need for better-quality studies with stringent controls and larger samples, said researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 3 days ago

Gels utilizing Stichopus horrens (golden sea cucumber/gamat) extract show a similar efficacy to standard-of-care hydrogels for promoting wound healing, according to a prospective study.

16 Mar 2019
Sleep difficulties are exacerbated in long-term survivors of childhood cancers, which may lead to persistent emotional distress, a new study has found.
2 days ago
Higher cancer symptom burden in elderly adults is associated with functional impairment, reports a recent study.
Jairia Dela Cruz, 5 days ago
Use of mirabegron in the treatment of men with overactive bladder (OAB) appears to effectively alleviate urgency and storage symptoms, but not reduce the frequency of micturition episodes, according to data from the MIRACLE study.